STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
36 hedge funds and large institutions have $87.7M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 3 closing their positions.
Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
11
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SC
1
Samlyn Capital
New York
|
$10.6M |
| 2 |
2
Walleye Capital
New York
|
$995K |
| 3 |
3
Barclays
London,
United Kingdom
|
$769K |
| 4 |
4
Ameriprise
Minneapolis,
Minnesota
|
$2.86M |
| 5 |
IC
5
Ikarian Capital
Dallas,
Texas
|
$2.48M |
